Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462-01
Published December 9, 2020 · Recall initiated: November 25, 2020
Summary
FDA records drug Class I recall D-0166-2021, published December 9, 2020 and initiated November 25, 2020. Recalling firm: Torrent Pharma Inc; Status: Terminated; Reported quantity: 2496 Bottles; Lot: Batch BFD1G001, exp 12/2021. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if ANAGRELIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ANAGRELIDE
- Manufacturer
- Torrent Pharma Inc
- Distributor
- Nationwide USA and Puerto Rico
- Lot
- Batch BFD1G001, exp 12/2021
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClobetasol Propionate Ointment USP 0.05%, Net Wt. 50 grams, Rx Only, Teligent Pharma. Inc. Buena, NJ 08310 NDCDecember 9, 2020
- FDATizanidine Tablets, USP 4mg, Rx Only, 150 Tablets per Bottle, Manufactured by Alkem Laboratories Ltd, Mumbai -December 9, 2020
- FDAREGENECARE HA (Lidocaine HCL 2%) Topical Anesthetic Hydrogel, Net Wt. 3 oz. (85 g), Manufactured For: MPMDecember 9, 2020
- FDAPacific Jade Indian Curry Sauce Starter With Fenugreek and Cardamom, wholesale case with 2, 39 oz. plasticDecember 9, 2020
- FDALevocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: MarlexDecember 9, 2020
- FDAAnagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc.,September 25, 2019
Questions about this recall
Was Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462-01 recalled?
Yes. FDA published recall D-0166-2021 on December 9, 2020. Reported hazard: Failed Dissolution Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ANAGRELIDE.